Pharmaceutical group ยท Tรผrkiye
A group of 6 companies with 9 medicines in 2 countries.
6 companies in 2 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMOXICILLIN AND CLAVULANATE POTASSIUM250mg; 125mg base | 500mg; 125mg base | 875mg; 125mg base ยท Tablet | Amoxicillin, Clavulanic acid | United States | Marketed | 2002 |
| ISOPROTERENOL HYDROCHLORIDE0.02mg/ml | 0.2mg/ml ยท Injectable | Isoprenaline | United States | Marketed | 1974 |
| TEMOZOLOMIDE100mg | 140mg | 180mg | 20mg | 250mg | 5mg ยท Capsule | Temozolomide | United States | Marketed | 2010 |
| IMATIS 100MG F.C.TABLET | Imatinib | Saudi Arabia | Authorised | |
| IMATIS 400MG F.C.TABLET | Imatinib | Saudi Arabia | Authorised | |
| LETRASAN 2.5MG F.C.TABLET | Letrozole | Saudi Arabia | Authorised | |
| LUXAT 10mg Film Coated Tablet | Montelukast | Saudi Arabia | Authorised | |
| QUET 100 mg Film-coated Tablet | Quetiapine | Saudi Arabia | Authorised | |
| QUET 200 mg Film-coated Tablet | Quetiapine | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 6 | 6 | 0 | CompaniesAll medicines |
| United States | 3 | 3 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Colombia, Malaysia, Singapore
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Keep DEVAโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
